Intracellular expression profile and clinical significance of the CCR9-CCL25 chemokine receptor complex in nasopharyngeal carcinoma

Journal of Laryngology and Otology

Volumn 129, Issue 10, 2015, Pages 1013-1019

  Ye, L F ^a   Huang, J ^a   Zhang, L P ^a   Chen, Z ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Chemokines, CC; Nasopharyngeal Neoplasms

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCL25; CHEMOKINE RECEPTOR CCR9; MESSENGER RNA; UNCLASSIFIED DRUG; BETA CHEMOKINE; CC CHEMOKINE RECEPTOR 9; CCL25 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NASOPHARYNX; NASOPHARYNX CARCINOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY;

ADULT; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHEMOKINES, CC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RECEPTORS, CCR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84944156069     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215115002108     Document Type: Article

References (34)

1. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992; 23: 261-70
2. Ahmad A, Stefani S. Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients. J Surg Oncol 1986; 33: 194-7
3. Cho WC. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 2007; 6: 1-3
4. Glastonbury CM. Nasopharyngeal carcinoma: the role of magnetic resonance imaging in diagnosis, staging, treatment, and follow-up. Top Magn Reson Imaging 2007; 18: 225-35
5. Balkwill F. Cancer and the chemokine network. Nature 2004; 4: 540-50
6. Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD et al. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol 2000; 165: 5069-76
7. Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 2002; 195: 1145-54
8. Zaballos A, Gutiérrez J, Varona R, Ardavín C, Márquez G. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol 1999; 162: 5671-5
9. Svensson M, Marsal J, Ericsson A, Carramolino L, Brodén T, Márquez G et al. CCL25 mediates the localization of recently activated CD8αβ+ lymphocytes to the small-intestinal mucosa. J Clin Invest 2002; 110: 1113-21
10. Eksteen B, Grant AJ, Miles A, Curbishley SM, Lalor PF, Hübscher SG et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 2004; 200: 1511-17
11. Connor SJ, Paraskevopoulos N, Newman R, Cuan N, Hampartzoumian T, Lloyd AR et al. CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohns disease. Gut 2004; 53: 1287-94
12. Hieshima K, Kawasaki Y, Hanamoto H, Nakayama T, Nagakubo D, Kanamaru A et al. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J Immunol 2004; 173: 3668-75
13. Annels NE, Willemze AJ, van der Velden VH, Faaij CM, van Wering E, Sie-Go DM et al. Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL. Blood 2004; 103: 2806-8
14. Sobin LH, Wittekind C, eds. International Union Against Cancer. TNM Classification of Malignant Tumours, 6th edn. Hoboken: John Wiley & Sons, 2002
15. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow. Lancet 2001; 357: 539-45
16. Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: friends or foes?. Clin Exp Metastasis 2002; 19: 247-58
17. Coussens LM, Werb Z. Cancer and inflammation. Nature 2002; 420: 860-7
18. Negus RP, Stamp GW, Hadley J, Balkwill FR. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-Cchemokines. Am J Pathol 1997; 150: 1723-34
19. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71-8
20. Balkwill F. Chemokine biology in cancer. Semin Immunol 2003; 15: 49-55
21. Kidd S, Caldwell L, Dietrich M, Samudio I, Spaeth EL, Watson K, Mesenchymal stromal cells alone or expressing interferonbeta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. Cytotherapy 2010; 12: 615-25
22. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow. Lancet 2001; 357: 539-45
23. Bottazzi B, Polentarutti N, Acero R, Balsari A, Boraschi D, Ghezzi P et al. Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983; 220: 210-12
24. Dhawan P, Richmond A. Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 2002; 72: 9-18
25. Hu Y, Zhang L, Wu R, Han R, Jia Y, Jiang Z et al. Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin. Leuk Res 2011; 35: 1254-60
26. Mohle R, Failenschmid C, Bautz F, Kanz L. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1). Leukemia 1999; 13: 1954-59
27. Möhle R, Schittenhelm M, Failenschmid C, Bautz F, Kratz-Albers K, Serve H et al. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br J Haematol 2000; 110: 563-72
28. Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S. Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur J Haematol 2000; 64: 323-32
29. Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW Jr. Expression and functional role of CCR9 in prostate cancer migration and invasion. Clin Cancer Res 2004; 24: 8743-50
30. Heinrich EL, Arrington AK, Ko ME, Luu C, Lee W, Lu J et al. Paracrine activation of chemokine receptor CCR9 enhances the invasiveness of pancreatic cancer cells. Cancer Microenviron 2013; 6: 241-45
31. Fusi A, Liu Z, Kummerlen V, Nonnemacher A, Jeske J, Keilholz U. Expression of chemokine receptors on circulating tumor cells in patients with solid tumors. J Transl Med 2012; 10: 52-5
32. Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Partridge EE et al. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. World J Surg Oncol 2010; 8: 62-5
33. Johnson-Holiday C, Singh R, Johnson E, Singh S, Stockard CR, Grizzle WE et al. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. Int J Oncol 2011; 38: 1279-85
34. Kuhnelt-Leddihn L, Muller H, Eisendle K, Zelger B, Weinlich G. Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?. Arch Dermatol Res 2012; 304: 185-93